ICC revealed remarkably increased production of GRP78, CHOP, phosphorylation-PERK (p-PERK), and cleaved ATF6 in the four GBM cell lines treated with SSD compared with that of control cells (Figure 3(a)). This evidence concerns the gene HSPA5 and intrahepatic cholangiocarcinoma.